INVO Fertility (IVF) Net Equity Issued and Repurchased (2011 - 2025)
INVO Fertility's (IVF) quarterly Net Equity Issued and Repurchased came in at $8.7 million in Q1 2025, up 38048.56% on a QoQ basis from -$23052.0 in Q4 2023.
INVO Fertility (IVF) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
INVO Fertility (IVF) has 10 years of Net Equity Issued and Repurchased data on file, last reported at $8.7 million in Q1 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $8.7 million in Q1 2025; TTM through Sep 2025 was $8.7 million, a 194.24% increase from a year earlier, with the FY2024 full-year figure at $165131.0, down 97.1% from the prior year.
- Net Equity Issued and Repurchased for Q1 2025 stood at $8.7 million, up from -$23052.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for IVF reached as high as $8.7 million in Q1 2025 and fell as low as -$23052.0 in Q4 2023.
- Historically, Net Equity Issued and Repurchased has averaged $1.8 million across 3 years, with a median of $164469.0 in 2022.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 29473.16% in 2023 and fell as far as 326.0% in 2023.
- Year by year, Net Equity Issued and Repurchased stood at $10200.0 in 2022, then plunged by 326.0% to -$23052.0 in 2023, then jumped by 38048.56% to $8.7 million in 2025.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $8.7 million in Q1 2025, -$23052.0 in Q4 2023, and $3.0 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 8.75 Mn |
| Mar 31, 2025 | 8.75 Mn |
| Dec 31, 2023 | -23,052.00 |
| Dec 31, 2023 | -23,052.00 |
| Sep 30, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.00 Mn |
| Jun 30, 2023 | 28,938.00 |
| Jun 30, 2023 | 28,938.00 |
| Mar 31, 2023 | 2.70 Mn |
| Mar 31, 2023 | 2.70 Mn |
| Dec 31, 2022 | 10,200.00 |
| Dec 31, 2022 | 10,200.00 |
| Sep 30, 2022 | -10,200.00 |
| Sep 30, 2022 | -10,200.00 |
| Mar 31, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Sep 30, 2018 | 30,000.00 |
| Sep 30, 2018 | 30,000.00 |
| Jun 30, 2018 | 30,000.00 |
| Jun 30, 2018 | 30,000.00 |